"rheumatoid factors" trang 7 - tải miễn phí từ tailieunhanh
Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis

Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis
10    45    1
Identification of myeloid-derived suppressor cells in the synovial fluid of patients with rheumatoid arthritis: A pilot study

Identification of myeloid-derived suppressor cells in the synovial fluid of patients with rheumatoid arthritis: A pilot study
7    19    1
Generalized bone loss in early rheumatoid arthritis patients followed for ten years in the biologic treatment era

Generalized bone loss in early rheumatoid arthritis patients followed for ten years in the biologic treatment era
9    13    1
The perplexity of prescribing and switching of biologic drugs in rheumatoid arthritis: A UK regional audit of practice

The perplexity of prescribing and switching of biologic drugs in rheumatoid arthritis: A UK regional audit of practice
8    22    1
The neutrophil protein S100A12 is associated with a comprehensive ultrasonographic synovitis score in a longitudinal study of patients with rheumatoid arthritis treated with adalimumab

The neutrophil protein S100A12 is associated with a comprehensive ultrasonographic synovitis score in a longitudinal study of patients with rheumatoid arthritis treated with adalimumab
5    42    1
A Q-methodology study of flare help-seeking behaviours and different experiences of daily life in rheumatoid arthritis

A Q-methodology study of flare help-seeking behaviours and different experiences of daily life in rheumatoid arthritis
13    55    1
Comparison of the efficacy and safety profiles of a pelubiprofen versus celecoxib in patients with rheumatoid arthritis: A 6-week, multicenter, randomized, double-blind, phase III, noninferiority clinical trial

Comparison of the efficacy and safety profiles of a pelubiprofen versus celecoxib in patients with rheumatoid arthritis: A 6-week, multicenter, randomized, double-blind, phase III, noninferiority clinical trial
9    35    1
Lack of association of matrix metalloproteinase-3 gene polymorphism with susceptibility to rheumatoid arthritis: A meta-analysis

Lack of association of matrix metalloproteinase-3 gene polymorphism with susceptibility to rheumatoid arthritis: A meta-analysis
8    24    1
Increased nocturnal periodic limb movements in rheumatoid arthritis patients meeting questionnaire diagnostic criteria for restless legs syndrome

Increased nocturnal periodic limb movements in rheumatoid arthritis patients meeting questionnaire diagnostic criteria for restless legs syndrome
5    26    1
The rheumatoid arthritis treat-to-target trial: A cluster randomized trial within the Corrona rheumatology network

The rheumatoid arthritis treat-to-target trial: A cluster randomized trial within the Corrona rheumatology network
7    37    1
Evaluation of tocilizumab therapy in patients with rheumatoid arthritis based on FDG-PET/CT

Evaluation of tocilizumab therapy in patients with rheumatoid arthritis based on FDG-PET/CT
7    22    1
A three month controlled intervention of intermittent whole body vibration designed to improve functional ability and attenuate bone loss in patients with rheumatoid arthritis

A three month controlled intervention of intermittent whole body vibration designed to improve functional ability and attenuate bone loss in patients with rheumatoid arthritis
7    43    1
Increased proteasome activator 28 gamma (PA28γ) levels are unspecific but correlate with disease activity in rheumatoid arthritis

Increased proteasome activator 28 gamma (PA28γ) levels are unspecific but correlate with disease activity in rheumatoid arthritis
10    44    1
Design characteristics of the CORRONA CERTAIN study: A comparative effectiveness study of biologic agents for rheumatoid arthritis patients

Design characteristics of the CORRONA CERTAIN study: A comparative effectiveness study of biologic agents for rheumatoid arthritis patients
10    38    1
Safety of infusing rituximab at a more rapid rate in patients with rheumatoid arthritis: Results from the RATE-RA study

Safety of infusing rituximab at a more rapid rate in patients with rheumatoid arthritis: Results from the RATE-RA study
9    30    1
Influence of antiTNF-alpha antibody treatment on fracture healing under chronic inflammation

Influence of antiTNF-alpha antibody treatment on fracture healing under chronic inflammation
6    44    1
Clinical characteristics of rheumatoid arthritis patients undergoing cervical spine surgery: An analysis of National Database of Rheumatic Diseases in Japan

Clinical characteristics of rheumatoid arthritis patients undergoing cervical spine surgery: An analysis of National Database of Rheumatic Diseases in Japan
8    36    1
An administrative data validation study of the accuracy of algorithms for identifying rheumatoid arthritis: The influence of the reference standard on algorithm performance

An administrative data validation study of the accuracy of algorithms for identifying rheumatoid arthritis: The influence of the reference standard on algorithm performance
9    29    1
Clinical and radiological dissociation of anti-TNF plus methotrexate treatment in early rheumatoid arthritis in routine care: Results from the ABRAB study

Clinical and radiological dissociation of anti-TNF plus methotrexate treatment in early rheumatoid arthritis in routine care: Results from the ABRAB study
7    31    1
Presence of the full-length KIR2DS4 gene reduces the chance of rheumatoid arthritis patients to respond to methotrexate treatment

Presence of the full-length KIR2DS4 gene reduces the chance of rheumatoid arthritis patients to respond to methotrexate treatment
6    40    1